Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
An open, randomized, controlled, phase II study to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals’ 11-valent pneumococcal conjugate vaccine, when administered intramuscularly as a 3, 5, 12 month vaccination schedule, as part of a staggered vaccination schedule https://kusajili.com:443/Trial/KqdI_irkUkGpJfPBC_Rbqw%24an-open-randomized-controlled-phase-ii-study-to-evaluate-the-safety-and-immunogenicity-of-glaxosmithkline-biologicals-11-valent
I have read and accept the terms of use of the site and the Privacy Policy
Send your message